News

Recent news and press releases

Kiox secures 1.97 million DKK to Accelerate Clinical Readiness 11. september 2025 - We are happy to announce that Kiox Pharma has secured a 1.97 million DKK grant from Innovation Fund Denmark. This funding will support the continued development of our inhaled treatment for Chronic Lung Allograft Dysfunction (CLAD). Completion of these activities will allow us to initiate clinical trial next year
Kiox joins 12.1 mil DKK Innovation Fund Denmark Grand Solution project 22. maj 2025 - Together with Silvi.ai we have engaged in a project to discover new targets and explore treatment options for rare lung diseases. #rarelungdiseases
Kiox raise 2.2m dkk to continue development of treatments for rare lung diseases 9. februar 2024 - With the investment Kiox will finalise product development on KX01 before moving into clinical trials. We have further strengthened our pipeline with another inhaled therapy (KX03) that now enters pre-clinical development.
Innovation Fund Denmark awards Kiox grant for research in interstitial lung diseases 12. juni 2023 - Kiox is accepted into the Innobooster program by Innovation Fund Denmark. The grant will fund development of a new treatments for interstitial lung disases.
Kiox partners with Iconovo to develop inhaled treatments for rare lung diseases 9. juni 2023 - Iconovo is a leading inhalation formulation and device company based in Lund, Sweden. Kiox andIconovo will work on developing inhaled treatment for rare lung diseases.